Evidence map›Paper›PMID 24151865›Full record

ArticleJournal of cutaneous pathology2014

Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases.

Phyu Phyu Aung, Fina Climent, Tariq Muzzafar, Jonathan L Curry, Keyur P Patel, Octavio Servitje, Victor G Prieto, Madeleine Duvic, Elaine S Jaffe, Carlos A Torres-Cabala

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of cutaneous pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Diagnosis of T-cell lymphoid proliferations of the skin: putting all the pieces together.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020
    Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Phyu Phyu AungNational Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Fina Climent
Tariq Muzzafar
Jonathan L Curry
Keyur P Patel
Octavio Servitje
Victor G Prieto
Madeleine Duvic
Elaine S Jaffe
Carlos A Torres-Cabala
The University of Texas MD Anderson Cancer Center · USBellvitge University Hospital · ESIn-Q-Tel · USNational Cancer Institute · USNational Institutes of Health · US

Funding

Lymphoma Disease Discovery and DefintionZIASC000550 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI JAFFE, ELAINE · 2009 to 2025
$16.9M
Hematopathology DiagnosisZIABC011070 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI JAFFE, ELAINE · 2009 to 2025
$14.5M
Hematopathology FellowshipZIEBC011241 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI JAFFE, ELAINE · 2009 to 2025
$11.1M
Lymphoma Disease Discovery and DefintionZ01SC000550 · SC · DIVISION OF CLINICAL SCIENCES - NCI · PI JAFFE, ELAINE · 1996 to 2008
$2.3M
Intramural NIH HHS Z01 SC000550
6 · The paper itself

Abstract

Primary cutaneous T-cell lymphomas (CTCL) comprise a heterogeneous group of neoplasms with diverse clinical behavior. Mycosis fungoides (MF) is the most common type of CTCL. Immunophenotypical shift during progression of the disease is a rare event and its significance is unknown. We present three primary CTCL cases that showed an immunophenotypical shift and poor prognosis. Conventional hematoxylin/eosin and immunohistochemical-stained sections were examined in all the cases. Molecular analysis for rearrangement of the T-cell receptor (TCR) gene was performed in two cases. One case was classified as MF, while the other two lacked epidermotropism, and were considered primary cutaneous peripheral T-cell lymphoma (PTCL), NOS. Two cases were CD3+/CD4+ and one case was CD3+/CD8+ at diagnosis. The first two patients suffered many relapses and eventually, new CTCL lesions with a CD3+/CD8+ phenotype were observed. Both cases revealed identical clonal TCR rearrangements on the initial and late lesions, supporting the interpretation of a single clonal proliferation with different phenotypes. The third case progressed with skin recurrences and pulmonary lesions with a predominant CD3+/CD4+/CD8- phenotype. All cases manifested poor prognosis and two patients died of lymphoma. Immunophenotypical shift between CD4 and CD8 in CTCL seems to be a rare phenomenon that may be associated with disease progression.

Indexed as

AdultAgedCD4 AntigensCD8 AntigensDisease ProgressionFemaleHumansImmunophenotypingLymphoma, T-Cell, CutaneousMaleMiddle AgedPrognosisReceptors, Antigen, T-CellSkinSkin NeoplasmsCD4 AntigensCD8 AntigensReceptors, Antigen, T-Cellcutaneous T-cell lymphoma (CTCL)immunohistochemistryimmunophenotypemycosis fungoides (MF)T-cell receptor gene rearrangement (PCR technique)

Identifiers

PMID24151865
PMCPMC6324548
OpenAlexW2153659390

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.